Micallef Jacob Vincent — SEC Form 4 filings
SEC reporting owner CIK 1651671. 16 Form 4 filings on record with FilingPulse; latest filed 2026-03-19.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-01-26 to 2026-03-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 93,691 shares, $46,500 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: purchase of 43,691 shares @ $0.57 ($25,000) in VOLITIONRX LTD, filed 2024-12-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| VOLITIONRX LTD (VNRX) | Chief Scientific Officer | 16 | 2 legs · 93,691 sh · $46,500 | — | 15 |
Form 4 filings — Micallef Jacob Vincent
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-19 | 4 | VOLITIONRX LTD (VNRX) | Tax withholding (F): 5,310 @ $0.19 | EDGAR |
| 2026-02-27 | 4 | VOLITIONRX LTD (VNRX) | Grant/award (A): 149,000 @ $0 | EDGAR |
| 2026-01-23 | 4 | VOLITIONRX LTD (VNRX) | Grant/award (A): 35,400 @ $0 | EDGAR |
| 2025-10-07 | 4 | VOLITIONRX LTD (VNRX) | Tax withholding (F): 5,850 @ $0.65 | EDGAR |
| 2025-09-30 | 4 | VOLITIONRX LTD (VNRX) | Tax withholding (F): 5,568 @ $0.60 | EDGAR |
| 2025-06-03 | 4 | VOLITIONRX LTD (VNRX) | Tax withholding (F): 21,526 @ $0.50 | EDGAR |
| 2025-05-19 | 4 | VOLITIONRX LTD (VNRX) | Purchase (P): 50,000 @ $0.43 | EDGAR |
| 2025-05-05 | 4 | VOLITIONRX LTD (VNRX) | Tax withholding (F): 18,319 @ $0.49 | EDGAR |
| 2025-01-31 | 4 | VOLITIONRX LTD (VNRX) | Disposition to issuer (D): 50,000 (derivative) · Grant/award (A): 50,000 (derivative) | EDGAR |
| 2024-12-10 | 4 | VOLITIONRX LTD (VNRX) | Purchase (P): 43,691 @ $0.57 | EDGAR |
| 2024-10-08 | 4 | VOLITIONRX LTD (VNRX) | Tax withholding (F): 5,200 @ $0.88 | EDGAR |
| 2024-10-01 | 4 | VOLITIONRX LTD (VNRX) | Tax withholding (F): 4,950 @ $0.58 | EDGAR |
| 2024-09-04 | 4 | VOLITIONRX LTD (VNRX) | Grant/award (A): 47,837 @ $0 | EDGAR |
| 2024-08-16 | 4 | VOLITIONRX LTD (VNRX) | Grant/award (A): 13,750 @ $0 | EDGAR |
| 2024-06-04 | 4 | VOLITIONRX LTD (VNRX) | Grant/award (A): 40,709 @ $0 | EDGAR |
| 2024-01-26 | 4 | VOLITIONRX LTD (VNRX) | Grant/award (A): 23,375 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1651671 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →